CD22-directed Immunoconjugate [EPC] - N0000193617

Pharmacologic Class Information

Pharmacologic Code N0000193617
Pharmacologic Name CD22-directed Immunoconjugate
Pharmacologic Uses
  • CD22-directed antibody-drug conjugate (ADC)
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with CD22-directed Immunoconjugate

The table contains 1 products whose active ingredient are classified under the same pharmacologic class CD22-directed Immunoconjugate [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0008-0100Besponsa Non-Proprietary Name: Inotuzumab OzogamicinInjection, Powder, Lyophilized, For SolutionIntravenousWyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.ACTIVE